These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 8725189)
1. Approximation of arterial input curve data in MRI estimation of cerebral blood-tumor-barrier leakage: comparison between Gd-DTPA and 99mTc-DTPA input curves. Andersen C; Taagehøj JF; Mühler A; Rehling M Magn Reson Imaging; 1996; 14(3):235-41. PubMed ID: 8725189 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic analysis of blood distribution of intravenously administered 153Gd-labeled Gd(DTPA)2- and 99mTc(DTPA) in rats. Wedeking P; Eaton S; Covell DG; Nair S; Tweedle MF; Eckelman WC Magn Reson Imaging; 1990; 8(5):567-75. PubMed ID: 2082126 [TBL] [Abstract][Full Text] [Related]
3. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs. Benness G; Khangure M; Morris I; Warwick A; Burrows P Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327 [TBL] [Abstract][Full Text] [Related]
4. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs. Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960 [TBL] [Abstract][Full Text] [Related]
5. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields. Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480 [TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors. Kovar DA; Lewis MZ; River JN; Lipton MJ; Karczmar GS Magn Reson Med; 1997 Aug; 38(2):259-68. PubMed ID: 9256106 [TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance renography: optimisation of pulse sequence parameters and Gd-DTPA dose, and comparison with radionuclide renography. Taylor J; Summers PE; Keevil SF; Saks AM; Diskin J; Hilton PJ; Ayers AB Magn Reson Imaging; 1997; 15(6):637-49. PubMed ID: 9285803 [TBL] [Abstract][Full Text] [Related]
8. Does gadolinium-diethylene triamine pentaacetic acid enhanced MRI of kidney represent tissue concentration of contrast media in the kidney? In vivo and in vitro study. Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T Magn Reson Imaging; 1994; 12(3):421-7. PubMed ID: 8007771 [TBL] [Abstract][Full Text] [Related]
9. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Fritz-Hansen T; Rostrup E; Larsson HB; Søndergaard L; Ring P; Henriksen O Magn Reson Med; 1996 Aug; 36(2):225-31. PubMed ID: 8843376 [TBL] [Abstract][Full Text] [Related]
10. Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning--a comparison of methods. Larsson HB; Tofts PS Magn Reson Med; 1992 Mar; 24(1):174-6. PubMed ID: 1556924 [TBL] [Abstract][Full Text] [Related]
11. Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection. Berkowitz BA; Sato Y; Wilson CA; de Juan E Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2854-60. PubMed ID: 1917389 [TBL] [Abstract][Full Text] [Related]
12. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging. Gowland P; Mansfield P; Bullock P; Stehling M; Worthington B; Firth J Magn Reson Med; 1992 Aug; 26(2):241-58. PubMed ID: 1513249 [TBL] [Abstract][Full Text] [Related]
13. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Tweedle MF; Wedeking P; Kumar K Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190 [TBL] [Abstract][Full Text] [Related]
14. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Quantitative Lung Perfusion Imaging Using the Dual-Bolus Approach: Comparison of 3 Contrast Agents and Recommendation of Feasible Doses. Veldhoen S; Oechsner M; Fischer A; Weng AM; Kunz AS; Bley TA; Köstler H; Ritter CO Invest Radiol; 2016 Mar; 51(3):186-93. PubMed ID: 26606550 [TBL] [Abstract][Full Text] [Related]
15. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents. Puttagunta NR; Gibby WA; Smith GT Invest Radiol; 1996 Dec; 31(12):739-42. PubMed ID: 8970874 [TBL] [Abstract][Full Text] [Related]
16. Dyke Award Paper. Kinetics of pathologic blood-brain-barrier permeability in an astrocytic glioma using contrast-enhanced MR. Schmiedl UP; Kenney J; Maravilla KR AJNR Am J Neuroradiol; 1992; 13(1):5-14. PubMed ID: 1595491 [TBL] [Abstract][Full Text] [Related]
17. Assessment of magnetic resonance contrast enhancement with Gd-DTPA: comparison with the uptake of Tc-99m-DTPA. Suto Y; Caner BE; Tamagawa Y; Matsuda T; Nakashima T; Matsushita T; Odori T; Ishii Y; Torizuka K Radiat Med; 1989; 7(5):209-13. PubMed ID: 2697892 [TBL] [Abstract][Full Text] [Related]
18. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Larsson HB; Stubgaard M; Frederiksen JL; Jensen M; Henriksen O; Paulson OB Magn Reson Med; 1990 Oct; 16(1):117-31. PubMed ID: 2255233 [TBL] [Abstract][Full Text] [Related]
19. In vivo quantification of the unidirectional influx constant for Gd-DTPA diffusion across the myocardial capillaries with MR imaging. Larsson HB; Stubgaard M; Søndergaard L; Henriksen O J Magn Reson Imaging; 1994; 4(3):433-40. PubMed ID: 8061444 [TBL] [Abstract][Full Text] [Related]
20. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Choyke PL; Austin HA; Frank JA; Girton ME; Diggs RL; Dwyer AJ; Miller L; Nussenblatt R; McFarland H; Simon T Kidney Int; 1992 Jun; 41(6):1595-8. PubMed ID: 1501414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]